| Chikungunya virus |
Chikungunya virus |
Activity |
19.0 |
% |
10.1016/j.bmc.2023.117239 |
| Chlorocebus sabaeus |
Vero |
CC50 |
50000.0 |
nM |
10.1101/2020.03.20.999730 |
| Chlorocebus sabaeus |
Vero C1008 |
CC50 |
16780.0 |
nM |
10.6019/CHEMBL4495565 |
| Cricetulus griseus |
CHO |
IC50 |
147157.0 |
nM |
10.1016/j.bmc.2015.07.051 |
| dengue virus type 2 |
dengue virus type 2 |
EC50 |
1080.0 |
nM |
10.1021/acs.jmedchem.5b01653 |
| dengue virus type 2 |
dengue virus type 2 |
EC50 |
7410.0 |
nM |
10.1021/acs.jmedchem.5b01653 |
| dengue virus type 2 |
dengue virus type 2 |
IC50 |
1080.0 |
nM |
10.1016/j.ejmech.2019.05.010 |
| dengue virus type 2 |
dengue virus type 2 |
IC90 |
2690.0 |
nM |
10.1016/j.ejmech.2019.05.010 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Aldehyde oxidase |
Drug metabolism |
nan |
None |
10.1021/acs.jmedchem.9b01895 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
4800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Amyloid-beta A4 protein |
FC |
0.4 |
None |
10.1016/j.bmc.2018.03.016 |
| Homo sapiens |
Amyloid-beta A4 protein |
FC |
0.5 |
None |
10.1016/j.bmc.2018.03.016 |
| Homo sapiens |
Amyloid-beta A4 protein |
IC50 |
4000.0 |
nM |
10.1016/j.bmc.2018.03.016 |
| Homo sapiens |
Amyloid-beta A4 protein |
IC50 |
5400.0 |
nM |
10.1016/j.bmc.2018.03.016 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
77760.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cathepsin B |
Inhibition |
nan |
% |
10.1016/j.ejmech.2018.10.061 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
6599.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
41000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2B6 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C8 |
CL |
0.608 |
mL.min-1.g-1 |
10.1124/dmd.112.047373 |
| Homo sapiens |
Cytochrome P450 2C8 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2C8 |
Km |
1900.0 |
nM |
10.1124/dmd.112.047373 |
| Homo sapiens |
Cytochrome P450 2C8 |
Vmax |
1460.0 |
pmol/min |
10.1124/dmd.112.047373 |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
640.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
7.7 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2J2 |
Activity |
22.5 |
% |
10.1124/dmd.111.043505 |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
990.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
10.0 |
% |
10.1124/dmd.111.039180 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dihydroorotate dehydrogenase |
Activity |
nan |
None |
10.1016/j.ejmech.2016.09.073 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
8900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
16000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HeLa |
Activity |
nan |
None |
10.1016/j.ejmech.2018.10.061 |
| Homo sapiens |
HepG2 |
EC50 |
nan |
None |
10.1016/j.ejmech.2015.07.047 |
| Homo sapiens |
HERG |
AC50 |
650.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
9800.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Huh-7 |
Inhibition |
-5.0 |
% |
10.1101/2020.04.13.039917 |
| Homo sapiens |
Huh-7 |
Inhibition |
1.0 |
% |
10.1101/2020.04.13.039917 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Liver microsome |
CL |
2.1e-05 |
mL.min-1.g-1 |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsome |
CL |
0.224 |
mL.min-1.g-1 |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
CL |
0.829 |
mL.min-1.g-1 |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
Drug metabolism |
2.1 |
pmol/min |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsome |
Km |
3330.0 |
nM |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
Km |
5170.0 |
nM |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
PB |
208.1 |
pmol |
10.1124/dmd.111.039180 |
| Homo sapiens |
Liver microsome |
Vmax |
1180.0 |
pmol/min |
10.1124/dmd.112.047373 |
| Homo sapiens |
Liver microsome |
Vmax |
2770.0 |
pmol/min |
10.1124/dmd.112.047373 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
25999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
7900.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 1 |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00894 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 2 |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00894 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 2 |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c01779 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 2 |
EC50 |
20000.0 |
nM |
10.1021/acs.jmedchem.2c00585 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 2 |
EC50 |
36000.0 |
nM |
10.1021/acs.jmedchem.0c01779 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 2 |
EC50 |
41000.0 |
nM |
10.1021/acs.jmedchem.1c01077 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 2 |
EC50 |
82000.0 |
nM |
10.1021/acs.jmedchem.1c01077 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 2 |
FC |
3.6 |
None |
10.1021/acs.jmedchem.0c01779 |
| Homo sapiens |
Nuclear receptor subfamily 4 group A member 3 |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00894 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
1500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serum albumin |
pKa |
0.12 |
None |
10.1021/acs.jmedchem.0c00046 |
| Homo sapiens |
Serum albumin |
pKa |
0.64 |
None |
10.1021/acs.jmedchem.0c00046 |
| Homo sapiens |
Serum albumin |
PPB |
78.8 |
% |
10.1021/acs.jmedchem.0c00046 |
| Homo sapiens |
SH-SY5Y |
CC50 |
10000.0 |
nM |
10.1016/j.bmc.2018.03.016 |
| Homo sapiens |
SK-N-BE(2) |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00894 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mesocricetus auratus |
BHK-21 |
CC50 |
52090.0 |
nM |
10.1021/acs.jmedchem.5b01653 |
| Plasmodium berghei |
Plasmodium berghei |
Activity |
99.0 |
% |
10.1021/acs.jmedchem.0c01104 |
| Plasmodium berghei |
Plasmodium berghei |
Activity |
99.9 |
% |
10.1016/j.bmc.2015.07.051 |
| Plasmodium berghei |
Plasmodium berghei |
Activity |
100.0 |
% |
10.1016/j.bmc.2015.07.051 |
| Plasmodium berghei |
Plasmodium berghei |
Activity |
100.0 |
% |
10.1021/acsmedchemlett.8b00496 |
| Plasmodium berghei |
Plasmodium berghei |
Activity |
100.0 |
% |
10.1021/jm500942v |
| Plasmodium berghei |
Plasmodium berghei |
Activity |
nan |
None |
10.1016/j.bmc.2015.07.051 |
| Plasmodium berghei |
Plasmodium berghei |
Activity |
nan |
None |
10.1021/acsmedchemlett.8b00496 |
| Plasmodium berghei |
Plasmodium berghei |
ED50 |
1.187 |
mg.kg-1 |
10.1016/j.ejmech.2016.06.033 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
28.02 |
% |
10.1016/j.ejmech.2016.06.033 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
48.24 |
% |
10.1016/j.ejmech.2016.06.033 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
67.14 |
% |
10.1016/j.ejmech.2016.06.033 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
94.07 |
% |
10.1016/j.ejmech.2016.06.033 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
95.5 |
% |
10.1021/acs.jmedchem.6b00759 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
95.5 |
% |
10.1021/acs.jmedchem.7b00738 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
95.5 |
% |
10.1021/jm500942v |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
99.0 |
% |
10.1021/acs.jmedchem.6b00752 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
99.8 |
% |
10.1021/jm500942v |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
99.9 |
% |
10.1021/acs.jmedchem.6b00759 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
99.9 |
% |
10.1021/acs.jmedchem.7b00738 |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
99.9 |
% |
10.1021/jm500942v |
| Plasmodium berghei |
Plasmodium berghei |
Inhibition |
100.0 |
% |
10.1016/j.ejmech.2016.09.073 |
| Plasmodium berghei |
Plasmodium berghei |
MSD |
30.0 |
day |
10.1016/j.bmc.2015.07.051 |
| Plasmodium berghei |
Plasmodium berghei |
MSD |
nan |
None |
10.1016/j.bmc.2015.07.051 |
| Plasmodium berghei |
Plasmodium berghei |
MST |
28.0 |
day |
10.1021/acsmedchemlett.8b00496 |
| Plasmodium berghei |
Plasmodium berghei |
Survival |
23.0 |
% |
10.1021/jm500942v |
| Plasmodium falciparum |
Hemozoin |
IC50 |
8600.0 |
nM |
10.1021/acs.jmedchem.0c02022 |
| Plasmodium falciparum |
Hemozoin |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c01516 |
| Plasmodium falciparum |
Hemozoin |
IC50 |
13000.0 |
nM |
10.1039/C8MD00608C |
| Plasmodium falciparum |
Hemozoin |
IC50 |
21000.0 |
nM |
10.1021/acs.jmedchem.6b00719 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
5.85 |
nM |
10.1016/j.ejmech.2015.07.047 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
12.3 |
nM |
10.1016/j.ejmech.2015.07.047 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
4.0 |
nM |
10.1016/j.bmc.2015.07.051 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
5.0 |
nM |
10.1016/j.bmc.2015.07.051 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
6.0 |
nM |
10.1016/j.bmc.2019.01.044 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
6.0 |
nM |
10.1016/j.ejmech.2016.09.073 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
8.0 |
nM |
10.1016/j.bmc.2015.07.051 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
17900.0 |
nM |
10.1016/j.ejmech.2019.111983 |
| Plasmodium falciparum |
Plasmodium falciparum |
Ratio IC50 |
1.6 |
None |
10.1016/j.bmc.2015.07.051 |
| Plasmodium falciparum |
Plasmodium falciparum |
Ratio IC50 |
2.5 |
None |
10.1016/j.bmc.2015.07.051 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
14.5 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1195 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
4070.0 |
nM |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
5150.0 |
nM |
10.1101/2020.03.20.999730 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
60.0 |
% |
10.1101/2020.04.13.039917 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
70.0 |
% |
10.1101/2020.04.13.039917 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
74.34 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
90.0 |
% |
10.1101/2020.04.13.039917 |
| Zaire ebolavirus |
Zaire ebolavirus |
Activity |
nan |
None |
10.1016/j.ejmech.2018.10.061 |
| Zika virus |
Zika virus |
EC50 |
2800.0 |
nM |
10.1021/acs.jmedchem.9b00775 |
| None |
ADMET |
Activity |
nan |
None |
10.1124/dmd.112.050054 |
| None |
ADMET |
CL |
0.021 |
uL/min |
10.1124/dmd.111.039180 |
| None |
ADMET |
CL |
32.36 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
150.0 |
mL.min-1.g-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
CL |
431.0 |
mL.min-1.g-1 |
10.1021/acsmedchemlett.8b00496 |
| None |
ADMET |
CL |
nan |
None |
10.1124/dmd.111.039180 |
| None |
ADMET |
IC50 |
500000.0 |
nM |
10.1124/dmd.112.050054 |
| None |
ADMET |
Inhibition |
25.0 |
% |
10.1124/dmd.112.050054 |
| None |
ADMET |
Ratio CC50/IC50 |
37.0 |
None |
10.1016/j.ejmech.2021.113220 |
| None |
ADMET |
Selectivity index |
4.12 |
None |
10.6019/CHEMBL4495565 |
| None |
ADMET |
Selectivity index |
9.71 |
None |
10.1101/2020.03.20.999730 |
| None |
ADMET |
T1/2 |
0.09 |
hr |
10.1021/acsmedchemlett.8b00496 |
| None |
No relevant target |
IC50 |
43500.0 |
nM |
10.1016/j.bmc.2015.07.051 |
| None |
No relevant target |
LogD7.4 |
2.9 |
None |
10.6019/CHEMBL3301361 |
| None |
Unchecked |
Activity |
79.0 |
% |
10.1016/j.ejmech.2016.09.073 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00894 |
| None |
Unchecked |
IC50 |
400000.0 |
nM |
10.1016/j.ejmech.2016.09.073 |
| None |
Unchecked |
Ratio EC50 |
nan |
None |
10.1016/j.ejmech.2015.07.047 |
| None |
Unchecked |
Ratio IC50 |
36789.25 |
None |
10.1016/j.bmc.2015.07.051 |